Stay Connected With Us

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy

Cancer Vaccine Platform
(Photo : Vincenzo Cerullo) This is a cancer vaccine platform, which consists of silver colored enveloped viruses, onto which a patient's cancer peptides has been tied to (in white, green and pink).

Researchers at the Faculty of Pharmacy have developed PeptiENV, a cancer vaccine platform, which can be used to improve the therapeutic efficacy of oncolytic enveloped viruses currently in clinical use. With the help of this new cancer vaccine platform, the activation of the human immune response against cancer cells becomes significantly more effective.

"What is actually the most remarkable insight concerning the PeptiENV cancer vaccine platform is that we are able to envelop oncolytic viruses with the patient's own cancer peptides, enabling tailored targeted treatment," says Erkko Ylösmäki, an Academy of Finland post-doctoral researcher working in the ImmunoViroTherapy Lab of the Faculty of Pharmacy, University of Helsinki.

Oncolytic viruses are naturally occurring viruses that have been modified to restrict their division into cancer cells only. Virotherapy is usually administered as an injection to the tumour or the abdominal cavity, or intravenously.

A virus enveloped with peptides through the PeptiENV platform can effectively "train" the patient's own, locally active T cells to identify tumour cells. Thus, the amount of T cells able to identify tumour cells increases in the cancerous tissue, improving the efficacy of the cancer therapy.

The study demonstrated the functionality of the PeptiENV cancer vaccine platform in conjunction with oncolytic enveloped herpes simplex virus 1, already used in the treatment of metastatic melanoma. Oncolytic vaccinia viruses, among others currently under investigation in clinical trials, are also compatible with the cancer vaccine platform.

Additionally, the number of T cells in the cancerous tissue that are able to identify cancer cells strongly correlates with the therapeutic effect of new immune checkpoint inhibitors.

"We aim to expand the pool of patients that could potentially benefit from the unparalleled efficacy of immune checkpoint inhibitors," Ylösmäki explains.

Oct 05, 2018 11:17 AM EDT By

MD News Daily

Right Now

Healthy Living 5 Benefits of Visiting A Dentist Regularly

5 Benefits of Visiting A Dentist Regularly
Medicine Where Do Unused and Expired Medications Go?

Where Do Unused and Expired Medications Go?

Don't Miss

Research Photo:

Tomatoes: Affordable Source of L-DOPA, Treament Drug for Parkinson's
Healthy Living Photo:

5 Everyday Foods That Slowly Harms Your Health
Why Your Medical Practice Needs To Be Accessible Both In-Person And Online Research

Why Your Medical Practice Needs To Be Accessible Both Physically And Online

As we enter into a period where equality, diversity, and inclusion are at the forefront of social agendas, it's becoming increasingly important for businesses, including medical clinics, to put steps in place to

BioVaxys: On the Cusp of Success for Cancer Vaccine Medicine

BioVaxys: On the Cusp of Success for Cancer Vaccine

The World Health Organisation categorizes cancer as the "second leading cause of death globally," and accounts for an estimated one in six deaths worldwide.
Product

Vaccine Temperature Monitoring Device

There's no running away from the fact that the healthcare facilities across the globe are trying hard to find a common ground when it comes to monitoring the temperature on the vaccine.
Real Time Analytics